Pneumonia Research Today is a free monthly online journal that collates and summarizes the latest research about Pneumonia, including details on symptoms, viral, bacterial, treatment, causes, walking pneumonia.

Volume 2 (2005), Issue 2 (February)

1. Prospective study of relationship between cytomegalovirus pneumonia and viral load in renal transplant recipients.
   Transplant Proc, 36(10): 3036-41. [Abstract] [Full-text]
2. Fatal acute fibrinous and organizing pneumonia in a child with juvenile dermatomyositis.
   J Pediatr, 146(2): 289-92. [Abstract] [Full-text]
3. Invasive Haemophilus influenzae type B diseases in Bangladesh, with increased resistance to antibiotics.
   J Pediatr, 146(2): 227-33. [Abstract] [Full-text]
4. Can chest X-ray predict pneumonia severity?
   Pediatr Pulmonol, 38(6): 465-9. [Abstract] [Full-text]
5. Expansile pneumonia in children caused by Mycobacterium tuberculosis: clinical, radiological, and bronchoscopic appearances.
   Pediatr Pulmonol, 38(6): 451-5. [Abstract] [Full-text]
6. The etiology of extensive pleural effusions with troublesome clinical course among children.
   Sao Paulo Med J, 122(6): 269-72. [Abstract] [Full-text]
7. Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice.
   J Allergy Clin Immunol, 115(2): 405-11. [Abstract] [Full-text]
8. IP-10 mediates selective mononuclear cell accumulation and activation in response to intrapulmonary transgenic expression and during adenovirus-induced pulmonary inflammation.
   J Interferon Cytokine Res, 25(2): 103-12. [Abstract] [Full-text]
9. Arterial carbon dioxide tension on admission as a marker of in-hospital mortality in community-acquired pneumonia.
   Am J Med, 118(2): 145-50. [Abstract] [Full-text]
10. Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect.
    Am J Physiol Lung Cell Mol Physiol, 288(3): L514-22. [Abstract] [Full-text]
11. Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia.
    Diagn Microbiol Infect Dis, 51(2): 103-11. [Abstract] [Full-text]
12. Etiology and outcomes of veterans with spinal cord injury and disorders hospitalized with community-acquired pneumonia.
    Arch Phys Med Rehabil, 86(2): 262-7. [Abstract] [Full-text]
13. Early treatment with pentoxifylline reduces lung injury induced by acid aspiration in rats.
    Chest, 127(2): 613-21. [Abstract] [Full-text]
14. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures.
    Chest, 127(2): 589-97. [Abstract] [Full-text]
15. Pneumococcal pneumonia in the UK--how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV).
    Vaccine, 23(14): 1739-45. [Abstract] [Full-text]
16. Serological diagnosis of enzootic pneumonia of swine by a double-sandwich enzyme-linked immunosorbent assay using a monoclonal antibody and recombinant antigen (P46) of Mycoplasma hyopneumoniae.
    Vet Microbiol, 105(3): 251-9. [Abstract] [Full-text]
17. Antibody response to GroEL varies in patients with acute Mycoplasma pneumoniae infection.
    FEMS Immunol Med Microbiol, 43(3): 399-406. [Abstract] [Full-text]
18. Risk factors of mortality for nosocomial pneumonia: importance of initial anti-microbial therapy.
    Int J Clin Pract, 59(1): 39-45. [Abstract] [Full-text]
19. S100A8 chemotactic protein is abundantly increased, but only a minor contributor to LPS-induced, steroid resistant neutrophilic lung inflammation in vivo.
    J Proteome Res, 4(1): 136-45. [Abstract] [Full-text]
20. Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice.
    Am J Respir Cell Mol Biol, 32(3): 201-10. [Abstract] [Full-text]
21. Induced sputum 8-isoprostane concentrations in inflammatory airway diseases.
    Am J Respir Crit Care Med, 171(5): 426-30. [Abstract] [Full-text]
22. Relationship of small airway chymase-positive mast cells and lung function in severe asthma.
    Am J Respir Crit Care Med, 171(5): 431-9. [Abstract] [Full-text]
23. Clinical effect of intravenous ciprofloxacin on hospital-acquired pneumonia.
    J Infect Chemother, 11(1): 52-4. [Abstract] [Full-text]
24. In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients.
    Antimicrob Agents Chemother, 49(3): 1249-52. [Abstract] [Full-text]
25. Activity of gemifloxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.
    Antimicrob Agents Chemother, 49(3): 1046-54. [Abstract] [Full-text]
26. Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs differ.
    Antimicrob Agents Chemother, 49(3): 996-1001. [Abstract] [Full-text]
27. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.
    Infect Immun, 73(3): 1695-705. [Abstract] [Full-text]
28. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
    Infect Immun, 73(3): 1568-77. [Abstract] [Full-text]
29. Risk factors associated with development of ventilator associated pneumonia.
    J Coll Physicians Surg Pak, 15(2): 92-5. [Abstract] [Full-text]
30. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis.
    BMJ, 330(7489): 456. [Abstract] [Full-text]
31. Management of community-acquired pneumonia and secular trends at different hospitals.
    Respir Med, 99(3): 268-78. [Abstract] [Full-text]

© 2004-2008 Pneumonia Research Today. All Rights Reserved.